Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Guandalini

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Medicinal Chemistry|March 17, 2006
Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonistSerena Scapecchi, Rosanna Matucci, Cristina Bellucci, et al.
Journal of Medicinal Chemistry|September 14, 2007
Design, synthesis, and preliminary pharmacological evaluation of new quinoline derivatives as nicotinic ligandsLuca Guandalini, Monica Norcini, Katia Varani, et al.
Bioorganic & Medicinal Chemistry|December 19, 2012
New structure-activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR)Francesca Orlandi, Marcella Coronnello, Cristina Bellucci, et al.
Bioorganic & Medicinal Chemistry Letters|March 28, 2015
Substituted piperazines as nootropic agents: 2- or 3-phenyl derivatives structurally related to the cognition-enhancer DM235Luca Guandalini, Maria Vittoria Martino, Lorenzo Di Cesare Mannelli, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
EC18 as a Tool To Understand the Role of HCN4 Channels in Mediating Hyperpolarization-Activated Current in TissuesMaria Novella Romanelli, Martina Del Lungo, Luca Guandalini, et al.
Journal of Medicinal Chemistry|November 26, 2009
Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structureSerena Scapecchi, Marta Nesi, Rosanna Matucci, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Medicinal Chemistry|March 17, 2006
Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonistSerena Scapecchi, Rosanna Matucci, Cristina Bellucci, et al.
Journal of Medicinal Chemistry|September 14, 2007
Design, synthesis, and preliminary pharmacological evaluation of new quinoline derivatives as nicotinic ligandsLuca Guandalini, Monica Norcini, Katia Varani, et al.
Bioorganic & Medicinal Chemistry|December 19, 2012
New structure-activity relationship studies in a series of N,N-bis(cyclohexanol)amine aryl esters as potent reversers of P-glycoprotein-mediated multidrug resistance (MDR)Francesca Orlandi, Marcella Coronnello, Cristina Bellucci, et al.
Bioorganic & Medicinal Chemistry Letters|March 28, 2015
Substituted piperazines as nootropic agents: 2- or 3-phenyl derivatives structurally related to the cognition-enhancer DM235Luca Guandalini, Maria Vittoria Martino, Lorenzo Di Cesare Mannelli, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
EC18 as a Tool To Understand the Role of HCN4 Channels in Mediating Hyperpolarization-Activated Current in TissuesMaria Novella Romanelli, Martina Del Lungo, Luca Guandalini, et al.
Journal of Medicinal Chemistry|November 26, 2009
Synthesis, affinity profile and functional activity of potent chiral muscarinic antagonists with a pyrrolidinylfuran structureSerena Scapecchi, Marta Nesi, Rosanna Matucci, et al.
Pageof 4